Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Mar;33(2):193-7.
doi: 10.5152/balkanmedj.2016.16840. Epub 2016 Mar 1.

Comparing the Efficacy of 7%, 3% and 0.9% Saline in Moderate to Severe Bronchiolitis in Infants

Seçil Köse  1 , Ahmet Şehriyaroğlu  1 , Feyza Esen  1 , Ahmet Özdemir  1 , Zehra Kardaş  1 , Umut Altuğ  1 , Esef Karakuş  1 , Alper Özcan  1 , Ali Fatih Kısaarslan  1 , Ferhan Elmalı  2 , Yasemin Altuner Torun  1 , Mehmet Köse  3
Affiliations

Comparing the Efficacy of 7%, 3% and 0.9% Saline in Moderate to Severe Bronchiolitis in Infants

Seçil Köse et al. Balkan Med J. 2016 Mar.

Abstract

Background: There is no standard treatment option in acute bronchiolitis. 3-7% hypertonic saline (HS) seems to be the effective treatment choice for reducing the hospitalization day.

Aims: To compare the effect of nebulized 7% HS/salbutamol and 3% HS/salbutamol to 0.9% saline/salbutamol. The primary outcome measure was the effect of study drugs on the length of hospital stay (LOS). Secondary outcome measures were safety and efficacy in reducing the clinical severity score (CSS) at the 24 hours of the study.

Study design: Prospective, double-blinded randomized clinical study.

Methods: The study consists of 104 infants. Groups were constituted according to the treatment they received: These are, group A - 0.9% saline/salbutamol, group B -3% HS/salbutamol and group C-7% HS/salbutamol. Heart beat, Bronchiolitis CSS and oxygen saturation of the patients were determined before and after nebulization. The patients were monitored for adverse reactions.

Results: Length of hospital stay in group A, B and C were as follows; 72.0 (20-288) hours in group A, 64.0 (12-168) hours in group B and 60.0 (12-264) hours in group C. No significant differences was observed among three groups (p>0.05).

Conclusion: 7% HS and 3% HS does not have any effect to decrease LOS for infants with bronchiolitis.

Keywords: Bronchiolitis; hypertonic saline; infant.

PubMed Disclaimer

References

    1. Ralston SL, Lieberthal AS, Meissner HC, Alverson BK, Baley JE, Gadomski AM, et al. American Academy of Pediatrics Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics. 2014;134:e1474–502. http://dx.doi.org/10.1542/peds.2014-2742. - DOI - PubMed
    1. Zorc JJ, Hall CB. Bronchiolitis: recent evidence on diagnosis and management. Pediatrics. 2010;125:342–9. http://dx.doi.org/10.1542/peds.2009-2092. - DOI - PubMed
    1. Gadomski AM, Brower M. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev. 2014;6:CD001266. http://dx.doi.org/10.1002/14651858.cd001266.pub4. - DOI - PMC - PubMed
    1. Simşek-Kiper PO, Kiper N, Hasçelik G, Dolgun A, Yalçin E, Doğru-Ersöz D, et al. Emergency room management of acute bronchiolitis: a randomized trial of nebulized epinephrine. Turk J Pediatr. 2011;53:651–60. - PubMed
    1. Fernandes RM, Bialy LM, Vandermeer B, Tjosvold L, Plint AC, Patel H, et al. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev. 2013;6:CD004878. http://dx.doi.org/10.1002/14651858.cd004878.pub4. - DOI - PMC - PubMed

LinkOut - more resources